Venture capital investment in medical device companies reportedly throttled back during the 1st quarter, even as the value of medtech deals rose compared with the 4th quarter of 2013.
Venture capitalists put more skin in fewer deals during the 1st quarter, amid an overall decline in life science deals, according to a survey of VC shops.
The number of deals for the medical device & equipment sector dropped 37% to 61 transactions, but the total value of those deals rose 28% to $588 million, according to the MoneyTree report from PricewaterhouseCoopers LLP and the National Venture Capital Assn., based on data provided by Thomson Reuters.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1h5Z3Qb
Cap comentari:
Publica un comentari a l'entrada